| Carcinoma, Hepatocellular |
| Not yet recruiting | 4 | 1500 | RoW | Vitamin D3 | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Carcinoma, Hepatocellular | 06/16 | 12/26 | | |
NCT02435953: TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma |
|
|
| Recruiting | 4 | 1 | RoW | TACE, RFA | Ming Zhao | Hepatocellular Carcinoma, Chemoembolization, Therapeutic, Ablation Techniques, RFA | 05/23 | | | |
| Not yet recruiting | 4 | 340 | RoW | laparoscopic surgery(LS), RFA | Sun Yat-sen University, Second Military Medical University | Hepatocellular Carcinoma | 12/26 | 12/26 | | |
NCT02715492: Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. |
|
|
| Not yet recruiting | 3 | 40 | RoW | LMWH, Enoxaparin, TACE | Sherief Abd-Elsalam | HCC | 12/22 | 12/22 | | |
NCT02646137: Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma |
|
|
| Recruiting | 3 | 50 | RoW | Transarterial chemoembolization (TACE), Transarterial chemoembolization, Radiofrequency ablation combined with TACE, Microwave ablation combined with TACE | Sherief Abd-Elsalam, Tanta University | Liver Cancer | 12/23 | 12/23 | | |
NCT02632864: Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial |
|
|
| Recruiting | 2 | 66 | RoW | Proton arm | Samsung Medical Center | Liver Neoplasm, Proton Therapy | 10/19 | 11/22 | | |
NCT03081377: Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in HCC |
|
|
| Recruiting | 1 | 15 | US | Galunisertib 150mg by mouth twice a day, (LY2157299), SBRT | University of Pennsylvania | Hepatocellular Carcinoma | 09/18 | 09/20 | | |
NCT02082691: Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma |
|
|
| No Longer Available | N/A | | US | G-202 | Devalingam Mahalingam, GenSpera, Inc. | Hepatocellular Carcinoma | | | | |
NCT00589030: Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
|
|
| No Longer Available | N/A | | US | brachytherapy, yttrium Y 90 glass microspheres | City of Hope Medical Center | Liver Cancer | 09/14 | 09/14 | | |
NCT02448056: MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma |
|
|
| Not yet recruiting | N/A | 150 | RoW | | National Taiwan University Hospital, Far Eastern Memorial Hospital | Carcinoma, Hepatocellular, Marker, Biological | 05/17 | 05/25 | | |
NCT00701168: Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer |
|
|
| No Longer Available | N/A | | US | yttrium Y 90 microspheres (Therasphere®) | Leo W. Jenkins Cancer Center | Carcinoma, Hepatocellular, Neoplasm Metastasis | | | | |
NCT02131441: Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection |
|
|
| Recruiting | N/A | 2 | RoW | laparoscopic hepatectomy, open liver resection | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Laparoscopic Hepatectomy, Hepatocellular Carcinoma | 08/18 | 08/23 | | |
RHCC:BCLC-A, NCT02678806: Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion |
|
|
| Recruiting | N/A | 620 | RoW | Postoperative radiotherapy, Postoperative TACE | Guangxi Medical University | HepatoCellular Carcinoma | 11/18 | 11/22 | | |
NCT02514434: Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC] |
|
|
| Active, not recruiting | N/A | 416 | RoW | Ultrasonography, non-contrast MRI | Yonsei University | Compensated Liver Cirrhosis | 12/22 | 12/22 | | |
| Active, not recruiting | N/A | 440 | US | iodinated contrast dye, iodinated radiographic dye, motexafin gadolinium, Xcytrin, Eovist-enhanced MRI | American College of Radiology Imaging Network, National Cancer Institute (NCI) | Liver Cancer | 12/23 | 12/23 | | |